First Quadrant’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$43K Sell
2,224
-117,900
-98% -$2.11M 0.24% 31
2021
Q4
$2.07M Buy
+120,124
New +$2.05M 0.22% 96
2021
Q2
Sell
-8,600
Closed -$103K 556
2021
Q1
$103K Hold
8,600
0.01% 416
2020
Q4
$107K Buy
+8,600
New +$92.8K 0.01% 423
2020
Q3
Sell
-7,022
Closed -$98K 663
2020
Q2
$98K Buy
+7,022
New +$95.5K 0.01% 552
2019
Q3
Sell
-1,818
Closed -$26K 626
2019
Q2
$26K Hold
1,818
﹤0.01% 671
2019
Q1
$26K Sell
1,818
-12,740
-88% -$206K ﹤0.01% 670
2018
Q4
$254K Buy
14,558
+3,546
+32% +$57.6K 0.02% 489
2018
Q3
$168K Buy
11,012
+9,197
+507% +$132K ﹤0.01% 641
2018
Q2
$25K Hold
1,815
﹤0.01% 735
2018
Q1
$30K Hold
1,815
﹤0.01% 765
2017
Q4
$26K Buy
+1,815
New +$24.2K ﹤0.01% 872
2016
Q4
Sell
-1,009
Closed -$11K 871
2016
Q3
$11K Buy
1,009
+9
+0.9% +$105 ﹤0.01% 838
2016
Q2
$11K Hold
1,000
﹤0.01% 766
2016
Q1
$13K Buy
+1,000
New +$11K ﹤0.01% 737

Other funds holding INVA

First Quadrant's INVA Position: Q1 2022 in Review

First Quadrant reduced its Innoviva (INVA) stake by 98% in Q1 2022, selling an estimated $2.11M and leaving 2,224 shares worth $43K. The position accounts for 0.24% of the portfolio, ranked #31.

First Quadrant first reported a position in INVA in Q1 2016 and has held it in 15 quarters since. The position peaked at $2.07M in Q4 2021. 236 funds tracked by Wall St. Rank hold INVA as of Q1 2022.

  • First Quadrant held 2,224 shares of Innoviva worth $43K as of Q1 2022.
  • First Quadrant sold 117,900 Innoviva shares in Q1 2022, an estimated $2.11M.
  • Innoviva made up 0.24% of First Quadrant's portfolio in Q1 2022, its #31 holding.
  • First Quadrant first reported a position in Innoviva in Q1 2016 and has held it in 15 quarters since.
  • First Quadrant's Innoviva position peaked at $2.07M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held Innoviva as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.